Sheng Pao-Shi

Overview

Sheng Pao-Shi is a Taiwanese-American businessman and angel investor with a robust background in the pharmaceutical sector. He is the founder and Chairman of Bora Pharmaceuticals, the largest pharmaceutical company in Taiwan. Under his leadership, Bora Pharmaceuticals has expanded its operations significantly, offering contract development and manufacturing services to global clients. The company has also established subsidiaries in the United States and Canada, enhancing its international presence. In addition to his role at Bora Pharmaceuticals, Sheng has been involved in various investment activities. In 2021, he partnered with Taishin Healthcare Limited Partnership to invest up to NT$3 billion (approximately US$108 million) in contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). This collaboration aims to strengthen Taiwan's CDMO sector and enhance its global competitiveness. Sheng's investment strategy focuses on sectors such as healthcare and pharmaceuticals, targeting early-stage to late-stage companies. His investments are geographically diverse, encompassing Taiwan, the United States, Canada, Europe, and China. He typically invests between US$1 million and US$50 million, reflecting his commitment to supporting the growth and development of the pharmaceutical industry both domestically and internationally.

Investment Focus

• Strong management team
• Innovative products
• Scalable business model
• Clear regulatory pathway
• Potential for significant market impact

Portfolio Companies